Endothelial Cells at the Crossroad of Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Unifying Target for Dual Treatment
{{output}}
Atherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLD) are 2 highly prevalent conditions that frequently coexist and amplify each other's clinical burden. MASLD not only increases cardiovascular disease incidence but also promote... ...
